Glucagon-like peptide-1 receptor agonists, often referred to simply as GLP-1s, are used to treat type 2 diabetes, overweight, obesity, and more
By distribution channel, the online pharmacies segment held a 18% share of the market in 2025 and is expected to grow at the fastest CAGR of 20.8% during the projection period
Bowers K, Li Q, Bressler J, Avramopoulos D, Newschaffer C, Fallin MD (2011) Glutathione pathway gene variation and risk of autism spectrum disorders
Several GLP-1 receptor agonists including Ozempic, Wegovy, Rybelsus (now the Ozempic pill, and Mounjaro carry an FDA Black Box Warning (now known as a boxed warning), the agencys strongest safety alert
The effectiveness of Rhodiola rosea L
Older work characterized DSIP as a sleep-modulating peptide rather than a sedative, with a U-shaped activity curve where small doses or short infusions produced the strongest effect